Post date:18. March 2021 - 12:03
Our new Young Scientist Committee was elected at the General Assembly:
- Stefanie Höfer (TUM, middle)
- Aristeidis Papargyriou (TUM / Helmholtz Zentrum München, right)
- Andrea Terrasi (LMU, left)
A big thank you to our previous Committee:
Post date:11. March 2021 - 9:28
Chronic pancreatitis greatly increases the morbidity and mortality of affected patients. No blood-based biomarkers exist for the diagnosis of chronic pancreatitis.
With over 200 participants the First Virtual Göttingen-Munich-Marburg Pancreatic Cancer Meeting, was a great success.17. February 2021 - 11:41
With over 400.000 related deaths world-wide, pancreatic cancer remains a significant health burden and is the fourth most common cancer-related death, with an increase in incidence, and a five-year survival rate of less than 10%.
Max Reichert receives professorship for translational pancreatic cancer research – Bridging biomedical research and natural sciences11. January 2021 - 14:40
One of the greatest challenges in improving treatment strategies for pancreatic cancer patients is to translate results obtained in the basic research laboratory directly to patient care. To improve this process, known as translation, appropriate human model systems that are predictive of the clinic are needed.
Post date:1. December 2020 - 16:33
We are pleased to announce that Maria Robles (Principal Investigator P11) has been selected as one of thirty life scientists to become EMBO Young Investigator. She will join the existing network of 73 current and 384 former members of the programme.
Post date:30. November 2020 - 16:05
Maria Robles (Principal Investigator P11) will succeed Christina Scheel, who left Munich and the SFB 1321. We would like to take the opportunity to thank her for her contributions and to welcome our new member.
Photo: Roland M. Schmid, Maria Robles, Günter Schneider, Angelika Schnieke, Julia Mayerle (clockwise from back left)